Use of Saliva for COVID-19 Diagnosis

University of Milano Bicocca109 enrolled

Overview

Aim of the study is to evaluate the presence of SARS-CoV2 RNA in the saliva of patients with suspected or confirmed COVID-19 in order to validate the analysis of this type of sample for the diagnosis of SARS-CoV2 infections.

Study Type

OBSERVATIONAL

Enrollment

109

Conditions

SARS-CoV2 Infection

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients ≥ 18 years of age hospitalized in the COVID-19 wards of ASST Monza - San Gerardo Hospital with positive, weakly positive or negative nasopharyngeal swabs; initially assessed at the E.R.; symptomatic or asymptomatic with indication to hospitalization. * Informed consent freely granted and acquired before the start of the study. Exclusion Criteria: * Patients with significant clinical conditions which could interfere with the study in the opinion of the researchers.

Locations (1)

ASST MONZA - Ospedale San Gerardo

Monza, MB, Italy

Outcomes

Primary Outcomes

Presence of SARS-CoV2 RNA in the saliva of patient with suspected or confirmed COVID-19.

Positive - Negative

Time frame: Up to 52 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.